Close Menu

NEW YORK – Sample prep and diagnostic test technology developer Veravas and molecularly imprinted polymers (MIP) specialist MIP Diagnostics announced Friday they have entered into an agreement to develop, license, and supply a novel MIP for Veravas' sample preparation technology.

The agreement is meant to facilitate the creation of novel products to help diagnostic companies manage risks associated with interferences in current test designs, such as biotin.

To read the full story....

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.

Don't have a 360Dx or GenomeWeb account?
Register for Free.